Metabolic Associated Fatty Liver Disease With Prediabetes clinical trials

Explore recruiting metabolic associated fatty liver disease with prediabetes clinical trials.

Also recruiting in Europe

Metabolic Associated Fatty Liver Disease With Prediabetes trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Control strategies and pharmacogenetic study for the personalized treatment of fatty liver associated with metabolic dysfunction in patients with prediabetes.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metabolic Associated Fatty Liver Disease With Prediabetes trials by city

Metabolic Associated Fatty Liver Disease With Prediabetes in Toronto Metabolic Associated Fatty Liver Disease With Prediabetes in Vancouver Metabolic Associated Fatty Liver Disease With Prediabetes in Montreal Metabolic Associated Fatty Liver Disease With Prediabetes in Calgary Metabolic Associated Fatty Liver Disease With Prediabetes in Edmonton Metabolic Associated Fatty Liver Disease With Prediabetes in Ottawa Metabolic Associated Fatty Liver Disease With Prediabetes in Winnipeg Metabolic Associated Fatty Liver Disease With Prediabetes in Quebec City Metabolic Associated Fatty Liver Disease With Prediabetes in Hamilton Metabolic Associated Fatty Liver Disease With Prediabetes in Kitchener Metabolic Associated Fatty Liver Disease With Prediabetes in London Metabolic Associated Fatty Liver Disease With Prediabetes in Halifax Metabolic Associated Fatty Liver Disease With Prediabetes in New York Metabolic Associated Fatty Liver Disease With Prediabetes in Los Angeles Metabolic Associated Fatty Liver Disease With Prediabetes in Chicago Metabolic Associated Fatty Liver Disease With Prediabetes in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease